Funding cuts in medical research have emerged as a significant concern, especially with the recent halt of over $2 billion in federal grants to institutions like Harvard.These abrupt cuts disrupt vital systems like the SMART IRB, which oversees safety and ethics in studies involving human participants across multiple sites.